Products for Research Use Only
RegisterLogin

Daphnegiravone D

CAT: 0804-HY-N13121Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N13121Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Daphnegiravone D (compound 70) is an HDAC6 inhibitor with anti-hepatocellular carcinoma activity. Daphnegiravone D can induce apoptosis and selectively inhibit the proliferation of liver cancer cells through the p38 and JNK MAPK pathways[1].
CAS Number
2581826-37-9
UNSPSC
12352005
Target
Apoptosis; HDAC; p38 MAPK
Type
Natural Products
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
CANCER
Assay Protocol
https://www.medchemexpress.com/daphnegiravone-d.html
Smiles
O=C1C(OC)=C(C2=CC(C/C=C(C)\C)=C(O)C=C2)OC3=C(C/C=C(C)\C)C(O)=CC(O)=C31
Molecular Formula
C26H28O6
Molecular Weight
436.50
References & Citations
[1]Wang D, et al. A new Prenylated Flavonoid induces G0/G1 arrest and apoptosis through p38/JNK MAPK pathways in Human Hepatocellular Carcinoma cells. Sci Rep. 2017 Jul 18;7 (1) :5736.|[2]Chen JJ, et al. Network pharmacology predicted HDAC6 as a potential target of flavones from Daphne giraldii on hepatocellular carcinoma. Nat Prod Res. 2021 Sep;35 (18) :3171-3175.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported

Related Products

CatalogName
HY-N9914S-01D-Psicose-d
HY-N0379S11-01D-Mannose-d
HY-W018772S6-01D-Ribose-d
HY-128753S6-01D-Lyxose-d
HY-N7092S8-01D-Fructose-d
HY-P4549H-D-Ala-D-Ala-D-Ala-D-Ala-OH
HY-P3881(D-Arg1, D-Pro2, D-Phe7, D-His9) -Substance P
HY-W018772S7-01D-Ribose-d-1
HY-W415917D-Glycero-D-mannoheptose
HY-B0389S19-01D-Glucose-13C, d

Alternative Products

CatalogName
T89216-01Daphnegiravone D

Popular Products